Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Telma-MCT 50/6.25 Tablet ER

Prescription Icon
Prescription Required

Marketer

Glenmark Pharmaceuticals Ltd

Salt Composition

Chlorthalidone (6.25mg) + Metoprolol Succinate (50mg) + Telmisartan (40mg)

Overview Telma-MCT 50/6.25 Tablet ER

Micardis Plus 50/6.25 mg Extended-Release tablets combine medications to manage hypertension. This treatment lowers blood pressure by widening blood vessels and improving the heart's pumping efficiency. It also facilitates the elimination of excess fluid and electrolytes. This medication may be taken with or without food, but consistent timing is crucial for optimal results. Increased urination is a common effect; therefore, daytime administration, or at least four hours before sleep, is recommended. Dosage and frequency are determined by your physician based on individual needs and should be followed precisely. Continuous use, as prescribed, is necessary. Common side effects include nausea, diarrhea, indigestion, headache, and lightheadedness. Regular monitoring of kidney function and electrolyte levels is essential. Lifestyle modifications, including balanced nutrition, physical activity, and smoking cessation, complement this medication for maximum effectiveness. Increased fluid intake helps mitigate potential dryness and thirst. Prior to commencing treatment, inform your doctor about pregnancy, circulatory disorders, liver or kidney conditions, and all other medications being taken, as interactions can affect efficacy.

Primary Ingredients of Telma-MCT 50/6.25 Tablet ER

There is no text provided to rephrase.

Uses of Telma-MCT 50/6.25 Tablet ER

Elevated blood pressure

Major Benefits of Telma-MCT 50/6.25 Tablet ER:

Administer this medication precisely as your physician directs, adhering to the prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Telma-MCT 50/6.25 ER tablets can be consumed with or without food, although consistent timing is recommended.

Common Side effects of Telma-MCT 50/6.25 Tablet ER:

  • Nausea
  • Diarrhea
  • Upset stomach
  • Headache
  • Dizziness
  • Cold extremities
  • Numbness of extremity
  • Increased blood lipid level
  • Slow heart rate
  • Decreased blood pressure

How to use Telma-MCT 50/6.25 Tablet ER:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Telma-MCT 50/6.25 ER tablets can be administered with or without food, although consistent timing is recommended.

How Telma-MCT 50/6.25 Tablet ER works:

Chlorthalidone, a diuretic, facilitates the urinary excretion of excess fluid and select electrolytes. Its long-term effects include vasodilation and enhanced circulatory function. Metoprolol succinate, a beta-adrenergic blocking agent, reduces cardiac rate. Meanwhile, telmisartan, an angiotensin receptor blocker, lowers vascular resistance by inhibiting angiotensin II.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Telma-MCT 50/6.25 Tablet ER and alcohol is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Telma-MCT 50/6.25mg tablets pose a confirmed risk to a developing fetus and should not be taken during pregnancy. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known dangers. Always seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Telma-MCT 50/6.25 mg tablets are likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingUNSAFE

Extended-release Telma-MCT 50/6.25mg tablets can cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.

KidneyKidneyCAUTION

Patients with severe kidney impairment should exercise caution when using Telma-MCT 50/6.25 mg Extended-Release tablets. Dosage modification may be necessary; physician consultation is advised. This medication is generally unsuitable for individuals with such conditions.

LiverLiverCAUTION

Patients with hepatic impairment should use Telma-MCT 50/6.25 mg Extended-Release tablets cautiously, potentially requiring dosage modification. Medical advice is recommended. Telma-MCT 50/6.25 mg Extended-Release tablets are contraindicated in patients exhibiting severe liver dysfunction.

What if you forget to take Telma-MCT 50/6.25 Tablet ER :

Should you forget to take a Telma-MCT 50/6.25 ER tablet, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Telma-MCT 50/6.25 Tablet ER

LabelValue
Developing Habits No.
Treatment Category Heart
Telma-MCT 50/6.25 Tablet ...
125
MRP 145
13% off